Lessons from human mutations in PPARgamma (Q45265437)

11 December 2017

Lessons from human mutations in PPARgamma (English)

1 reference

11 December 2017

Hegele RA

1

1 reference

PubMed ID

15711581

11 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

International Journal of Obesity

11 December 2017

1 reference

11 December 2017

29 Suppl 1

1 reference

11 December 2017

S31-5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0802911

11 December 2017

0 references

cites work

Development of the multiple metabolic syndrome: an epidemiologic perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Adiponectin: a link between excess adiposity and associated comorbidities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Premature atherosclerosis associated with monogenic insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Life at the edge: the nuclear envelope and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

Pathophysiology of insulin resistance in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

Comment on the provisional report from the WHO consultation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21–22

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

Multisystem dystrophy syndrome due to novel missense mutations in the amino-terminal head and alpha-helical rod domains of the lamin A/C gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802911

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802911

1 reference

PubMed ID

15711581

Dimensions Publication ID

11 December 2017

0 references

1 reference

PubMed ID

15711581